8. Scher HI, Beer TM, Higano CS, Anand A, Taplin ME, Efstathiou E, Rathkopf D, Shelkey J, Yu EY, Alumkal J et al: Antitumour activity of MDV3100 in castration- resistant prostate cancer: a phase 1-2 study. Lancet 2010, 375(9724):1437-1446.